Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?
Henard S, Jeanmaire E, Nguyen Y, Yazdanpanah Y, Cheret A, Hoen B, Rey D, Borel A, Chavanet P, May T, Rabaud C; ICONE Group.
Henard S, et al. Among authors: borel a.
J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):400-2. doi: 10.1097/QAI.0b013e318263a111.
J Acquir Immune Defic Syndr. 2012.
PMID: 22732466